Circulating Tumor Cell Market - Global Outlook and Forecast 2021-2027

Code: RW00014575564
Market Monitor Global
Oct-2021
Life Sciences
112 Pages

This report contains market size and forecasts of Circulating Tumor Cell in Global, including the following market information:
Global Circulating Tumor Cell Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Circulating Tumor Cell market was valued at 6382.4 million in 2020 and is projected to reach US$ 9859 million by 2027, at a CAGR of 11.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Circulating Tumor Cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cell Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Circulating Tumor Cell Market Segment Percentages, By Type, 2020 (%)
CTC Enrichment
CTC Detection
CTC Analysis

China Circulating Tumor Cell Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Circulating Tumor Cell Market Segment Percentages, By Application, 2020 (%)
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others

Global Circulating Tumor Cell Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Circulating Tumor Cell Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Circulating Tumor Cell Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Circulating Tumor Cell Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Menarini-Silicon Biosystems
Qiagen?Adnagen?
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cell Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cell Overall Market Size
2.1 Global Circulating Tumor Cell Market Size: 2021 VS 2027
2.2 Global Circulating Tumor Cell Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cell Players in Global Market
3.2 Top Global Circulating Tumor Cell Companies Ranked by Revenue
3.3 Global Circulating Tumor Cell Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cell Companies in Global Market, by Revenue in 2020
3.5 Global Companies Circulating Tumor Cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cell Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cell Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cell Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Tumor Cell Market Size Markets, 2021 & 2027
4.1.2 CTC Enrichment
4.1.3 CTC Detection
4.1.4 CTC Analysis
4.2 By Type - Global Circulating Tumor Cell Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cell Revenue, 2016-2021
4.2.2 By Type - Global Circulating Tumor Cell Revenue, 2022-2027
4.2.3 By Type - Global Circulating Tumor Cell Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cell Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Colorectal Cancer
5.1.5 Others
5.2 By Application - Global Circulating Tumor Cell Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cell Revenue, 2016-2021
5.2.2 By Application - Global Circulating Tumor Cell Revenue, 2022-2027
5.2.3 By Application - Global Circulating Tumor Cell Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cell Market Size, 2021 & 2027
6.2 By Region - Global Circulating Tumor Cell Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cell Revenue, 2016-2021
6.2.2 By Region - Global Circulating Tumor Cell Revenue, 2022-2027
6.2.3 By Region - Global Circulating Tumor Cell Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cell Revenue, 2016-2027
6.3.2 US Circulating Tumor Cell Market Size, 2016-2027
6.3.3 Canada Circulating Tumor Cell Market Size, 2016-2027
6.3.4 Mexico Circulating Tumor Cell Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cell Revenue, 2016-2027
6.4.2 Germany Circulating Tumor Cell Market Size, 2016-2027
6.4.3 France Circulating Tumor Cell Market Size, 2016-2027
6.4.4 U.K. Circulating Tumor Cell Market Size, 2016-2027
6.4.5 Italy Circulating Tumor Cell Market Size, 2016-2027
6.4.6 Russia Circulating Tumor Cell Market Size, 2016-2027
6.4.7 Nordic Countries Circulating Tumor Cell Market Size, 2016-2027
6.4.8 Benelux Circulating Tumor Cell Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cell Revenue, 2016-2027
6.5.2 China Circulating Tumor Cell Market Size, 2016-2027
6.5.3 Japan Circulating Tumor Cell Market Size, 2016-2027
6.5.4 South Korea Circulating Tumor Cell Market Size, 2016-2027
6.5.5 Southeast Asia Circulating Tumor Cell Market Size, 2016-2027
6.5.6 India Circulating Tumor Cell Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cell Revenue, 2016-2027
6.6.2 Brazil Circulating Tumor Cell Market Size, 2016-2027
6.6.3 Argentina Circulating Tumor Cell Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cell Revenue, 2016-2027
6.7.2 Turkey Circulating Tumor Cell Market Size, 2016-2027
6.7.3 Israel Circulating Tumor Cell Market Size, 2016-2027
6.7.4 Saudi Arabia Circulating Tumor Cell Market Size, 2016-2027
6.7.5 UAE Circulating Tumor Cell Market Size, 2016-2027
7 Players Profiles
7.1 Menarini-Silicon Biosystems
7.1.1 Menarini-Silicon Biosystems Corporate Summary
7.1.2 Menarini-Silicon Biosystems Business Overview
7.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Major Product Offerings
7.1.4 Menarini-Silicon Biosystems Circulating Tumor Cell Revenue in Global (2016-2021)
7.1.5 Menarini-Silicon Biosystems Key News
7.2 Qiagen?Adnagen?
7.2.1 Qiagen?Adnagen? Corporate Summary
7.2.2 Qiagen?Adnagen? Business Overview
7.2.3 Qiagen?Adnagen? Circulating Tumor Cell Major Product Offerings
7.2.4 Qiagen?Adnagen? Circulating Tumor Cell Revenue in Global (2016-2021)
7.2.5 Qiagen?Adnagen? Key News
7.3 Clearbridge Biomedics
7.3.1 Clearbridge Biomedics Corporate Summary
7.3.2 Clearbridge Biomedics Business Overview
7.3.3 Clearbridge Biomedics Circulating Tumor Cell Major Product Offerings
7.3.4 Clearbridge Biomedics Circulating Tumor Cell Revenue in Global (2016-2021)
7.3.5 Clearbridge Biomedics Key News
7.4 Celsee
7.4.1 Celsee Corporate Summary
7.4.2 Celsee Business Overview
7.4.3 Celsee Circulating Tumor Cell Major Product Offerings
7.4.4 Celsee Circulating Tumor Cell Revenue in Global (2016-2021)
7.4.5 Celsee Key News
7.5 Fluidigm
7.5.1 Fluidigm Corporate Summary
7.5.2 Fluidigm Business Overview
7.5.3 Fluidigm Circulating Tumor Cell Major Product Offerings
7.5.4 Fluidigm Circulating Tumor Cell Revenue in Global (2016-2021)
7.5.5 Fluidigm Key News
7.6 ApoCell
7.6.1 ApoCell Corporate Summary
7.6.2 ApoCell Business Overview
7.6.3 ApoCell Circulating Tumor Cell Major Product Offerings
7.6.4 ApoCell Circulating Tumor Cell Revenue in Global (2016-2021)
7.6.5 ApoCell Key News
7.7 Greiner Bio-one
7.7.1 Greiner Bio-one Corporate Summary
7.7.2 Greiner Bio-one Business Overview
7.7.3 Greiner Bio-one Circulating Tumor Cell Major Product Offerings
7.4.4 Greiner Bio-one Circulating Tumor Cell Revenue in Global (2016-2021)
7.7.5 Greiner Bio-one Key News
7.8 Advanced Cell Diagnostics
7.8.1 Advanced Cell Diagnostics Corporate Summary
7.8.2 Advanced Cell Diagnostics Business Overview
7.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Major Product Offerings
7.8.4 Advanced Cell Diagnostics Circulating Tumor Cell Revenue in Global (2016-2021)
7.8.5 Advanced Cell Diagnostics Key News
7.9 Aviva Biosciences
7.9.1 Aviva Biosciences Corporate Summary
7.9.2 Aviva Biosciences Business Overview
7.9.3 Aviva Biosciences Circulating Tumor Cell Major Product Offerings
7.9.4 Aviva Biosciences Circulating Tumor Cell Revenue in Global (2016-2021)
7.9.5 Aviva Biosciences Key News
7.10 Fluxion Biosciences
7.10.1 Fluxion Biosciences Corporate Summary
7.10.2 Fluxion Biosciences Business Overview
7.10.3 Fluxion Biosciences Circulating Tumor Cell Major Product Offerings
7.10.4 Fluxion Biosciences Circulating Tumor Cell Revenue in Global (2016-2021)
7.10.5 Fluxion Biosciences Key News
7.11 Sysmex
7.11.1 Sysmex Corporate Summary
7.11.2 Sysmex Business Overview
7.11.3 Sysmex Circulating Tumor Cell Major Product Offerings
7.11.4 Sysmex Circulating Tumor Cell Revenue in Global (2016-2021)
7.11.5 Sysmex Key News
7.12 Epic Sciences
7.12.1 Epic Sciences Corporate Summary
7.12.2 Epic Sciences Business Overview
7.12.3 Epic Sciences Circulating Tumor Cell Major Product Offerings
7.12.4 Epic Sciences Circulating Tumor Cell Revenue in Global (2016-2021)
7.12.5 Epic Sciences Key News
7.13 Cynvenio
7.13.1 Cynvenio Corporate Summary
7.13.2 Cynvenio Business Overview
7.13.3 Cynvenio Circulating Tumor Cell Major Product Offerings
7.13.4 Cynvenio Circulating Tumor Cell Revenue in Global (2016-2021)
7.13.5 Cynvenio Key News
7.14 CytoTrack
7.14.1 CytoTrack Corporate Summary
7.14.2 CytoTrack Business Overview
7.14.3 CytoTrack Circulating Tumor Cell Major Product Offerings
7.14.4 CytoTrack Circulating Tumor Cell Revenue in Global (2016-2021)
7.14.5 CytoTrack Key News
7.15 Ikonisys
7.15.1 Ikonisys Corporate Summary
7.15.2 Ikonisys Business Overview
7.15.3 Ikonisys Circulating Tumor Cell Major Product Offerings
7.15.4 Ikonisys Circulating Tumor Cell Revenue in Global (2016-2021)
7.15.5 Ikonisys Key News
7.16 Vortex BioSciences
7.16.1 Vortex BioSciences Corporate Summary
7.16.2 Vortex BioSciences Business Overview
7.16.3 Vortex BioSciences Circulating Tumor Cell Major Product Offerings
7.16.4 Vortex BioSciences Circulating Tumor Cell Revenue in Global (2016-2021)
7.16.5 Vortex BioSciences Key News
7.17 Gilupi
7.17.1 Gilupi Corporate Summary
7.17.2 Gilupi Business Overview
7.17.3 Gilupi Circulating Tumor Cell Major Product Offerings
7.17.4 Gilupi Circulating Tumor Cell Revenue in Global (2016-2021)
7.17.5 Gilupi Key News
7.18 Biocept
7.18.1 Biocept Corporate Summary
7.18.2 Biocept Business Overview
7.18.3 Biocept Circulating Tumor Cell Major Product Offerings
7.18.4 Biocept Circulating Tumor Cell Revenue in Global (2016-2021)
7.18.5 Biocept Key News
7.19 ScreenCell
7.19.1 ScreenCell Corporate Summary
7.19.2 ScreenCell Business Overview
7.19.3 ScreenCell Circulating Tumor Cell Major Product Offerings
7.19.4 ScreenCell Circulating Tumor Cell Revenue in Global (2016-2021)
7.19.5 ScreenCell Key News
7.20 ANGLE
7.20.1 ANGLE Corporate Summary
7.20.2 ANGLE Business Overview
7.20.3 ANGLE Circulating Tumor Cell Major Product Offerings
7.20.4 ANGLE Circulating Tumor Cell Revenue in Global (2016-2021)
7.20.5 ANGLE Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Circulating Tumor Cell Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cell Market Drivers in Global Market
Table 3. Circulating Tumor Cell Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cell in Global Market
Table 5. Top Circulating Tumor Cell Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Circulating Tumor Cell Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Circulating Tumor Cell Revenue Share by Companies, 2016-2021
Table 8. Global Companies Circulating Tumor Cell Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cell Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cell Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE